135 related articles for article (PubMed ID: 16771171)
1. TrkA expression is associated with an elevated level of apoptosis in classic medulloblastomas.
Ohta T; Watanabe T; Katayama Y; Kurihara J; Yoshino A; Nishimoto H; Kishimoto H
Neuropathology; 2006 Jun; 26(3):170-7. PubMed ID: 16771171
[TBL] [Abstract][Full Text] [Related]
2. Neuron-associated class III beta-tubulin isotype, retinal S-antigen, synaptophysin, and glial fibrillary acidic protein in human medulloblastomas: a clinicopathological analysis of 36 cases.
Maraziotis T; Perentes E; Karamitopoulou E; Nakagawa Y; Gessaga EC; Probst A; Frankfurter A
Acta Neuropathol; 1992; 84(4):355-63. PubMed ID: 1441916
[TBL] [Abstract][Full Text] [Related]
3. A clinicobiological model predicting survival in medulloblastoma.
Ray A; Ho M; Ma J; Parkes RK; Mainprize TG; Ueda S; McLaughlin J; Bouffet E; Rutka JT; Hawkins CE
Clin Cancer Res; 2004 Nov; 10(22):7613-20. PubMed ID: 15569993
[TBL] [Abstract][Full Text] [Related]
4. Neurotrophins and neuronal versus glial differentiation in medulloblastomas and other pediatric brain tumors.
Tajima Y; Molina RP; Rorke LB; Kaplan DR; Radeke M; Feinstein SC; Lee VM; Trojanowski JQ
Acta Neuropathol; 1998 Apr; 95(4):325-32. PubMed ID: 9560008
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical markers for prognosis of average-risk pediatric medulloblastomas. The effect of apoptotic index, TrkC, and c-myc expression.
Korshunov A; Savostikova M; Ozerov S
J Neurooncol; 2002 Jul; 58(3):271-9. PubMed ID: 12187960
[TBL] [Abstract][Full Text] [Related]
6. Apoptosis, neuronal maturation, and neurotrophin expression within medulloblastoma nodules.
Eberhart CG; Kaufman WE; Tihan T; Burger PC
J Neuropathol Exp Neurol; 2001 May; 60(5):462-9. PubMed ID: 11379821
[TBL] [Abstract][Full Text] [Related]
7. A clinicopathologic and immunohistochemical analysis of 53 cases of medulloblastoma with emphasis on synaptophysin expression.
Coffin CM; Braun JT; Wick MR; Dehner LP
Mod Pathol; 1990 Mar; 3(2):164-70. PubMed ID: 2109316
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical expression of markers Ki-67, neun, synaptophysin, p53 and HER2 in medulloblastoma and its correlation with clinicopathological parameters.
Meurer RT; Martins DT; Hilbig A; Ribeiro Mde C; Roehe AV; Barbosa-Coutinho LM; Fernandes Mda C
Arq Neuropsiquiatr; 2008 Jun; 66(2B):385-90. PubMed ID: 18641877
[TBL] [Abstract][Full Text] [Related]
9. Histopathological and molecular prognostic markers in medulloblastoma: c-myc, N-myc, TrkC, and anaplasia.
Eberhart CG; Kratz J; Wang Y; Summers K; Stearns D; Cohen K; Dang CV; Burger PC
J Neuropathol Exp Neurol; 2004 May; 63(5):441-9. PubMed ID: 15198123
[TBL] [Abstract][Full Text] [Related]
10. Neurotrophin receptors and heparanase: a functional axis in human medulloblastoma invasion.
Marchetti D; Mrak RE; Paulsen DD; Sinnappah-Kang ND
J Exp Clin Cancer Res; 2007 Mar; 26(1):5-23. PubMed ID: 17550129
[TBL] [Abstract][Full Text] [Related]
11. Intense p53 staining is a valuable prognostic indicator for poor prognosis in medulloblastoma/central nervous system primitive neuroectodermal tumors.
Woodburn RT; Azzarelli B; Montebello JF; Goss IE
J Neurooncol; 2001 Mar; 52(1):57-62. PubMed ID: 11451203
[TBL] [Abstract][Full Text] [Related]
12. Medulloblastoma with extensive nodularity: a variant occurring in the very young-clinicopathological and immunohistochemical study of four cases.
Suresh TN; Santosh V; Yasha TC; Anandh B; Mohanty A; Indiradevi B; Sampath S; Shankar SK
Childs Nerv Syst; 2004 Jan; 20(1):55-60. PubMed ID: 14657995
[TBL] [Abstract][Full Text] [Related]
13. Prediction of prognosis in children with medulloblastoma by using immunohistochemical analysis and tissue microarray.
Shim KW; Joo SY; Kim SH; Choi JU; Kim DS
J Neurosurg Pediatr; 2008 Mar; 1(3):196-205. PubMed ID: 18352763
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical analysis for histopathological subtypes in pediatric medulloblastomas.
Son EI; Kim IM; Kim DW; Yim MB; Kang YN; Lee SS; Kwon KY; Suh SI; Kwon TK; Lee JJ; Kim DS; Kim SP
Pathol Int; 2003 Feb; 53(2):67-73. PubMed ID: 12588433
[TBL] [Abstract][Full Text] [Related]
15. Overexpressed TP73 induces apoptosis in medulloblastoma.
Castellino RC; De Bortoli M; Lin LL; Skapura DG; Rajan JA; Adesina AM; Perlaky L; Irwin MS; Kim JY
BMC Cancer; 2007 Jul; 7():127. PubMed ID: 17626635
[TBL] [Abstract][Full Text] [Related]
16. Medulloblastoma: evaluation of proliferative index by monoclonal antibody Mib-1, its prognostic correlation and therapeutic implications.
Ferrari AF; Araújo MB; Aguiar PH; Plese JP
Arq Neuropsiquiatr; 2003 Sep; 61(3A):547-51. PubMed ID: 14513155
[TBL] [Abstract][Full Text] [Related]
17. Medulloblastomas in childhood: histological factors influencing patients' outcome.
Taomoto K; Tomita T; Raimondi AJ; Leestma JE
Childs Nerv Syst; 1987; 3(6):354-60. PubMed ID: 3450387
[TBL] [Abstract][Full Text] [Related]
18. Bcl-2 expression inversely correlates with tumour cell differentiation in medulloblastoma.
Schüller U; Schober F; Kretzschmar HA; Herms J
Neuropathol Appl Neurobiol; 2004 Oct; 30(5):513-21. PubMed ID: 15488027
[TBL] [Abstract][Full Text] [Related]
19. DJ-1 is activated in medulloblastoma and is associated with cell proliferation and differentiation.
Lin JP; Pan BC; Li B; Li Y; Tian XY; Li Z
World J Surg Oncol; 2014 Dec; 12():373. PubMed ID: 25475127
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic markers in paediatric medulloblastoma: a Paediatric Oncology Group Study.
McLendon RE; Friedman HS; Fuchs HE; Kun LE; Bigner SH
Histopathology; 1999 Feb; 34(2):154-62. PubMed ID: 10064395
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
